(CSR) Centerspace - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US15202L1070
Stock: Apartment Homes, Rental Units, Residential Properties, Real Estate
Total Rating 38
Risk 40
Buy Signal -0.87
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.99% |
| Yield on Cost 5y | 5.26% |
| Yield CAGR 5y | 2.05% |
| Payout Consistency | 94.5% |
| Payout Ratio | 103.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.1% |
| Relative Tail Risk | -6.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -0.38 |
| Character TTM | |
|---|---|
| Beta | 0.401 |
| Beta Downside | 0.460 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.69% |
| CAGR/Max DD | 0.10 |
Description: CSR Centerspace January 19, 2026
Centerspace (NYSE: CSR) is a U.S.-based owner-operator of multifamily properties that emphasizes “integrity and serving others.” As of September 30 2025 the firm held 68 communities with 12,941 apartment units across Colorado, Minnesota, Montana, Nebraska, North Dakota, South Dakota, and Utah, and it earned a sixth-year “Top Workplace” accolade from the Minneapolis Star Tribune.
Key operating metrics that analysts watch for this niche REIT include occupancy, rent growth, and funds-from-operations (FFO). In Q4 2024 CSR reported an occupancy of roughly 96 % and a year-over-year rent increase of about 4.5 %, while diluted FFO per share was $0.68. The broader multifamily sector remains buoyed by strong migration to the Mountain-West states, a tight supply pipeline (≈1.2 % annual unit growth in the region), and a demographic tilt toward renters among households under 35 years old.
For a deeper dive into CSR’s valuation assumptions and scenario analysis, you may find ValueRay’s data platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -21.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.15 > 1.0 |
| NWC/Revenue: -186.2% < 20% (prev -124.2%; Δ -61.99% < -1%) |
| CFO/TA 0.05 > 3% & CFO 104.4m > Net Income -21.6m |
| Net Debt (509.2m) to EBITDA (113.5m): 4.49 < 3 |
| Current Ratio: 0.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.8m) vs 12m ago 27.32% < -2% |
| Gross Margin: 65.66% > 18% (prev 0.57%; Δ 6509 % > 0.5%) |
| Asset Turnover: 13.72% > 50% (prev 13.70%; Δ 0.02% > 0%) |
| Interest Coverage Ratio: 0.03 > 6 (EBITDA TTM 113.5m / Interest Expense TTM 43.1m) |
Altman Z'' -1.90
| A: -0.24 (Total Current Assets 12.9m - Total Current Liabilities 522.1m) / Total Assets 2.10b |
| B: -0.29 (Retained Earnings -618.3m / Total Assets 2.10b) |
| C: 0.00 (EBIT TTM 1.08m / Avg Total Assets 1.99b) |
| D: 0.62 (Book Value of Equity 748.6m / Total Liabilities 1.21b) |
| Altman-Z'' Score: -1.90 = D |
Beneish M -3.02
| DSRI: 1.17 (Receivables 25.9m/20.9m, Revenue 273.4m/258.6m) |
| GMI: 0.87 (GM 65.66% / 57.03%) |
| AQI: 1.00 (AQ_t 0.99 / AQ_t-1 0.99) |
| SGI: 1.06 (Revenue 273.4m / 258.6m) |
| TATA: -0.06 (NI -21.6m - CFO 104.4m) / TA 2.10b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of CSR shares?
As of February 07, 2026, the stock is trading at USD 64.25 with a total of 75,012 shares traded.
Over the past week, the price has changed by -0.03%, over one month by -3.15%, over three months by +8.31% and over the past year by +8.35%.
Over the past week, the price has changed by -0.03%, over one month by -3.15%, over three months by +8.31% and over the past year by +8.35%.
Is CSR a buy, sell or hold?
Centerspace has received a consensus analysts rating of 3.67.
Therefor, it is recommend to hold CSR.
- StrongBuy: 2
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CSR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.4 | 6.4% |
| Analysts Target Price | 68.4 | 6.4% |
| ValueRay Target Price | 67.4 | 5% |
CSR Fundamental Data Overview February 03, 2026
P/E Trailing = 35.5083
P/E Forward = 55.5556
P/S = 4.1659
P/B = 1.4355
Revenue TTM = 273.4m USD
EBIT TTM = 1.08m USD
EBITDA TTM = 113.5m USD
Long Term Debt = 921.6m USD (from longTermDebt, last quarter)
Short Term Debt = 522.1m USD (from shortTermDebt, last quarter)
Debt = 522.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 509.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.65b USD (1.14b + Debt 522.1m - CCE 12.9m)
Interest Coverage Ratio = 0.03 (Ebit TTM 1.08m / Interest Expense TTM 43.1m)
EV/FCF = 15.79x (Enterprise Value 1.65b / FCF TTM 104.4m)
FCF Yield = 6.33% (FCF TTM 104.4m / Enterprise Value 1.65b)
FCF Margin = 38.18% (FCF TTM 104.4m / Revenue TTM 273.4m)
Net Margin = -7.91% (Net Income TTM -21.6m / Revenue TTM 273.4m)
Gross Margin = 65.66% ((Revenue TTM 273.4m - Cost of Revenue TTM 93.9m) / Revenue TTM)
Gross Margin QoQ = 89.96% (prev 57.81%)
Tobins Q-Ratio = 0.79 (Enterprise Value 1.65b / Total Assets 2.10b)
Interest Expense / Debt = 2.49% (Interest Expense 13.0m / Debt 522.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = 855.6k (EBIT 1.08m * (1 - 21.00%))
Current Ratio = 0.02 (Total Current Assets 12.9m / Total Current Liabilities 522.1m)
Debt / Equity = 0.70 (Debt 522.1m / totalStockholderEquity, last quarter 748.6m)
Debt / EBITDA = 4.49 (Net Debt 509.2m / EBITDA 113.5m)
Debt / FCF = 4.88 (Net Debt 509.2m / FCF TTM 104.4m)
Total Stockholder Equity = 698.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.09% (Net Income -21.6m / Total Assets 2.10b)
RoE = -3.10% (Net Income TTM -21.6m / Total Stockholder Equity 698.5m)
RoCE = 0.07% (EBIT 1.08m / Capital Employed (Equity 698.5m + L.T.Debt 921.6m))
RoIC = 0.05% (NOPAT 855.6k / Invested Capital 1.73b)
WACC = 5.69% (E(1.14b)/V(1.66b) * Re(7.39%) + D(522.1m)/V(1.66b) * Rd(2.49%) * (1-Tc(0.21)))
Discount Rate = 7.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 14.76%
[DCF Debug] Terminal Value 85.13% ; FCFF base≈91.6m ; Y1≈81.8m ; Y5≈69.2m
Fair Price DCF = 94.79 (EV 2.09b - Net Debt 509.2m = Equity 1.58b / Shares 16.7m; r=5.90% [WACC]; 5y FCF grow -13.13% → 2.90% )
EPS Correlation: 21.18 | EPS CAGR: 131.9% | SUE: 0.22 | # QB: 0
Revenue Correlation: 71.68 | Revenue CAGR: 5.70% | SUE: 2.94 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.22 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.83 | Chg30d=+0.049 | Revisions Net=-3 | Growth EPS=+51.0% | Growth Revenue=+2.0%
P/E Forward = 55.5556
P/S = 4.1659
P/B = 1.4355
Revenue TTM = 273.4m USD
EBIT TTM = 1.08m USD
EBITDA TTM = 113.5m USD
Long Term Debt = 921.6m USD (from longTermDebt, last quarter)
Short Term Debt = 522.1m USD (from shortTermDebt, last quarter)
Debt = 522.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 509.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.65b USD (1.14b + Debt 522.1m - CCE 12.9m)
Interest Coverage Ratio = 0.03 (Ebit TTM 1.08m / Interest Expense TTM 43.1m)
EV/FCF = 15.79x (Enterprise Value 1.65b / FCF TTM 104.4m)
FCF Yield = 6.33% (FCF TTM 104.4m / Enterprise Value 1.65b)
FCF Margin = 38.18% (FCF TTM 104.4m / Revenue TTM 273.4m)
Net Margin = -7.91% (Net Income TTM -21.6m / Revenue TTM 273.4m)
Gross Margin = 65.66% ((Revenue TTM 273.4m - Cost of Revenue TTM 93.9m) / Revenue TTM)
Gross Margin QoQ = 89.96% (prev 57.81%)
Tobins Q-Ratio = 0.79 (Enterprise Value 1.65b / Total Assets 2.10b)
Interest Expense / Debt = 2.49% (Interest Expense 13.0m / Debt 522.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = 855.6k (EBIT 1.08m * (1 - 21.00%))
Current Ratio = 0.02 (Total Current Assets 12.9m / Total Current Liabilities 522.1m)
Debt / Equity = 0.70 (Debt 522.1m / totalStockholderEquity, last quarter 748.6m)
Debt / EBITDA = 4.49 (Net Debt 509.2m / EBITDA 113.5m)
Debt / FCF = 4.88 (Net Debt 509.2m / FCF TTM 104.4m)
Total Stockholder Equity = 698.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.09% (Net Income -21.6m / Total Assets 2.10b)
RoE = -3.10% (Net Income TTM -21.6m / Total Stockholder Equity 698.5m)
RoCE = 0.07% (EBIT 1.08m / Capital Employed (Equity 698.5m + L.T.Debt 921.6m))
RoIC = 0.05% (NOPAT 855.6k / Invested Capital 1.73b)
WACC = 5.69% (E(1.14b)/V(1.66b) * Re(7.39%) + D(522.1m)/V(1.66b) * Rd(2.49%) * (1-Tc(0.21)))
Discount Rate = 7.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 14.76%
[DCF Debug] Terminal Value 85.13% ; FCFF base≈91.6m ; Y1≈81.8m ; Y5≈69.2m
Fair Price DCF = 94.79 (EV 2.09b - Net Debt 509.2m = Equity 1.58b / Shares 16.7m; r=5.90% [WACC]; 5y FCF grow -13.13% → 2.90% )
EPS Correlation: 21.18 | EPS CAGR: 131.9% | SUE: 0.22 | # QB: 0
Revenue Correlation: 71.68 | Revenue CAGR: 5.70% | SUE: 2.94 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.22 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.83 | Chg30d=+0.049 | Revisions Net=-3 | Growth EPS=+51.0% | Growth Revenue=+2.0%